Chartwell Investment Partners, LLC Coherus Bio Sciences, Inc. Transaction History

Chartwell Investment Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 30, 2020	SELL	$11.67 - $22.53 $598,892 - $1.16 Million	-51,319 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$16.33 - $21.37 $1.71 Million - $2.24 Million	-104,762 Reduced 67.12%	51,319 $924,000
Q2 2019 Aug 19, 2019	BUY	$13.1 - $22.1 $2.04 Million - $3.45 Million	156,081 New	156,081 $3.45 Million

132

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.